4NH1
Crystal structure of a heterotetrameric CK2 holoenzyme complex carrying the Andante-mutation in CK2beta and consistent with proposed models of autoinhibition and trans-autophosphorylation
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06DA |
Synchrotron site | SLS |
Beamline | X06DA |
Collection date | 2012-06-12 |
Wavelength(s) | 1.0000 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 210.537, 57.441, 139.394 |
Unit cell angles | 90.00, 118.54, 90.00 |
Refinement procedure
Resolution | 46.237 - 3.300 |
R-factor | 0.215 |
Rwork | 0.213 |
R-free | 0.25140 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1jwh |
RMSD bond length | 0.003 |
RMSD bond angle | 0.632 |
Data reduction software | XDS |
Data scaling software | XSCALE (from XDS) |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.8.4_1496)) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 46.240 |
High resolution limit [Å] | 3.300 |
Rmerge | 0.050 |
Number of reflections | 21878 |
<I/σ(I)> | 13.85 |
Redundancy | 2.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |